Figure 3A shows that expression of IL-10, TGF-β, MMP-9 and VEGF in the tumor microenvironment was markedly reduced in the Cl2MDP liposome-treated group compared with that in the control vehicle-treated group. The gene discussed is VEGFA; the disease is neoplasm.